Clinical Results of the eyePlate-300 Published
We are excited to announce the publication of the first clinical results for the eyePlate-300, led by Dr. Faisal and his team. This study, involving 15 patients, provides important insights into the performance and safety of the eyePlate-300.
Key Findings:
- •Success Rates: The study reported an 83% overall success rate, with 47% achieving complete success.
- •IOP Reduction: Patients experienced a significant 67% reduction in intraocular pressure (IOP) at 1 year.
- •Medication Reduction: The average number of medications was reduced from 3.1 to 0.7 at 1 year.
- •Safety Profile: There were no severe complications, and no patients required reoperations.
- •No MMC Usage: Notably, Mitomycin C (MMC) was not used in any of the patients.
These results highlight the eyePlate-300 as a promising option for patients requiring effective and safe intraocular pressure management.
We extend our congratulations to Dr. Faisal and his team for their diligent work.
For more details, the full paper can be accessed here.